AGEN
#3142
Agenus Inc. - Common Stock
8.0 9 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.25%
Changement Mensuel
+3.06%
Evolution sur 6 mois
+152.02%
Changement Annuel
+90.80%
Clôture Précédente
7.9 9
Open
8.0 9
Low
8.0 9
High
8.0 9
Volume
50
Financials
- Market Capitalization 364.22 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.01
ratio cours/chiffre d'affaires
0.81
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3130 |  IRD Opus Genetics, Inc. - Common Stock | 4.45 USD | +16.19% | +14.99% | +21.25% | +19.62% | 370.22 M USD | ||
| 3137 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.96 USD | +2.96% | +2.12% | +16.24% | -38.16% | 366.60 M USD | ||
| 3143 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.75 USD | +4.65% | +1.05% | +2.27% | +27.60% | 364.00 M USD | ||
| 3182 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.50 USD | +5.04% | +0.81% | +11.11% | +44.51% | 348.84 M USD |